Advertisement
| bioaffinity technologies ipo date: Meshless Methods in Biomechanics Jorge Belinha, 2014-05-14 This book presents the complete formulation of a new advanced discretization meshless technique: the Natural Neighbour Radial Point Interpolation Method (NNRPIM). In addition, two of the most popular meshless methods, the EFGM and the RPIM, are fully presented. Being a truly meshless method, the major advantages of the NNRPIM over the FEM and other meshless methods, are the remeshing flexibility and the higher accuracy of the obtained variable field. Using the natural neighbour concept, the NNRPIM permits to determine organically the influence-domain, resembling the cellulae natural behaviour. This innovation permits the analysis of convex boundaries and extremely irregular meshes, which is an advantage in the biomechanical analysis, with no extra computational effort associated. This volume shows how to extend the NNRPIM to the bone tissue remodelling analysis, expecting to contribute with new numerical tools and strategies in order to permit a more efficient numerical biomechanical analysis. |
| bioaffinity technologies ipo date: Social Media and the 2008 U. S. Presidential Election Emily Metzgar, Albert Maruggi, 2009-10 The 2008 U.S. presidential campaign offered a unique opportunity to evaluate the usefulness and applicability of social media technology in the American political environment. This study's assessment of the role that social media played during the 2008 U.S. presidential campaign confirms some widely held tenets of conventional wisdom about social media, but it also indicates that the role of social media as the new sine qua non of American politics is far from certain. |
| bioaffinity technologies ipo date: Crash Proof Peter D. Schiff, John Downes, 2010-12-15 The economic tipping point for the United States is no longer theoretical. It is a reality today. The country has gone from the world's largest creditor to its greatest debtor; the value of the dollar is sinking; domestic manufacturing is winding down - and these trends don't seem to be slowing. Peter Schiff casts a sharp, clear-sighted eye on these factors and explains what the possible effects may be and how investors can protect themselves. For more than a decade, Schiff has not only observed the U.S. economy, but also helped his clients reposition their portfolios to reflect his outlook. What he sees is a nation facing an economic storm brought on by growing federal, personal, and corporate debt, too-little savings, a declining dollar, and lack of domestic manufacturing. Crash-Proof is an informed and informative warning of a looming period marked by sizeable tax hikes, loss of retirement benefits, double digit inflation, even - as happened recently in Argentina - the possible collapse of the middle class. However, Schiff does have a survival plan that can provide the protection that readers will need in the coming years. |
| bioaffinity technologies ipo date: The Wiley Handbook of Problem-Based Learning Mahnaz Moallem, Woei Hung, Nada Dabbagh, 2019-01-30 The first book to offer an in-depth exploration of the topic of problem-based learning with contributions from international experts The Wiley Handbook of Problem-Based Learning is the first book of its kind to present a collection of original essays that integrate the research and practice of problem-based learning in one comprehensive volume. With contributions from an international panel of leading scholars, researchers, practitioners and educational and training communities, the handbook is an authoritative, definitive, and contemporary volume that clearly demonstrates the impact and scope of research-based practice in problem-based learning (PBL). After many years of its successful implementation in medical education curricula, problem-based learning is now being emphasized and practiced more widely in K-12, higher education, and other professional fields. The handbook provides timely and stimulating advice and reflection on the theory, research, and practice of PBL. Throughout the book the contributors address the skills needed to implement PBL in the classroom and the need for creating learning environments that are active, collaborative, experiential, motivating and engaging. This important resource: Addresses the need for a comprehensive resource to problem-based learning research and implementation Contains contributions from an international panel of experts on the topic Offers a rich collection of scholarly writings that challenge readers to refresh their knowledge and rethink their assumptions Takes an inclusive approach that addresses the theory, design, and practice of problem-based learning Includes guidelines for instructional designers, and implementation and assessment strategies for practitioners Written for academics, students, and practitioners in education, The Wiley Handbook of Problem-Based Learning offers a key resource to the most recent information on the research and practice of problem-based learning. |
| bioaffinity technologies ipo date: Mindful Trading J. Rande Howell, 2010-11-17 This book explores how fear or impulsivity blocks the potential of the trader you could be. But more than just explaining HOW your fears and impulsivity negatively impact your trading, this book explains what you can DO about it.Through the use of real life vignettes, Rande tells the stories of traders like you who have wrestled with their psychological demons and conquered them. From the paralyzing hesitation of the fear of pulling the trigger to the demoralizing disaster of impulse trading to make up for prior loses, you will see how they overcame their self-limiting beliefs and achieved a disciplined, patient, impartial, and courageous mindset the Trader's State of Mind.Rande explores how these traders used Mindfulness as part of a process to develop an edge that led them to peak performance trading. In this book you will learn how to disrupt old self limiting beliefs that block you from your potential and awaken the potential of the Inner Trader living within you. |
| bioaffinity technologies ipo date: Once Upon a Dream Liz Braswell, 2016-04-05 What if the sleeping beauty never woke up? Once Upon a Dream marks the second book in a new YA line that reimagines classic Disney stories in surprising new ways. It should be simple--a dragon defeated, a slumbering princess in a castle, a prince poised to wake her. But when the prince falls asleep as his lips touch the fair maiden's, it is clear that this fairy tale is far from over. With a desperate fairy's last curse controlling her mind, Princess Aurora must escape from a different castle of thorns and navigate a dangerously magical landscape--created from her very own dreams. Aurora isn't alone--a charming prince is eager to join her quest, and old friends offer their help. But as Maleficent's agents follow her every move, Aurora struggles to discover who her true allies are and, moreover, who she truly is. Time is running out. Will the sleeping beauty be able to wake herself up? |
| bioaffinity technologies ipo date: Quality Management Audits in Nuclear Medicine Practices International Atomic Energy Agency, 2015-10-08 Quality management systems are essential and should be maintained with the intent to continuously improve effectiveness and efficiency, enabling nuclear medicine to achieve the expectations of its quality policy, satisfy its customers and improve professionalism. The quality management (QM) audit methodology in nuclear medicine practice, introduced in this publication, is designed to be applied to a variety of economic circumstances. A key outcome is a culture of reviewing all processes of the clinical service for continuous improvement in nuclear medicine practice. Regular quality audits and assessments are vital for modern nuclear medicine services. More importantly, the entire QM and audit process has to be systematic, patient oriented and outcome based. The management of services should also take into account the diversity of nuclear medicine services around the world and multidisciplinary contributions. The latter include clinical, technical, radiopharmaceutical, medical physics and radiation safety procedures. |
| bioaffinity technologies ipo date: Aquaculture Biotechnology Garth L. Fletcher, Matthew L. Rise, 2012-02-01 This important book looks at a broad spectrum of biotech research efforts and their applications to the aquaculture industry. Aquaculture Biotechnology provides key reviews that look at the application of genetic, cellular, and molecular technologies to enable fish farmers to produce a more abundant, resilient, and healthier supply of seafood. Aquaculture Biotechnology is divided into seven sections and nineteen chapters that cover topics ranging from broodstock improvement to fish health and gene transfer. With chapters provided by leading researchers and skillfully edited by top scientists in the field, this will be a valuable tool to researchers, producers, and students interested in better understanding this dynamic field of aquaculture. |
| bioaffinity technologies ipo date: Rice Improvement Jauhar Ali, Shabir Hussain Wani, 2021-05-05 This book is open access under a CC BY 4.0 license. By 2050, human population is expected to reach 9.7 billion. The demand for increased food production needs to be met from ever reducing resources of land, water and other environmental constraints. Rice remains the staple food source for a majority of the global populations, but especially in Asia where ninety percent of rice is grown and consumed. Climate change continues to impose abiotic and biotic stresses that curtail rice quality and yields. Researchers have been challenged to provide innovative solutions to maintain, or even increase, rice production. Amongst them, the ‘green super rice’ breeding strategy has been successful for leading the development and release of multiple abiotic and biotic stress tolerant rice varieties. Recent advances in plant molecular biology and biotechnologies have led to the identification of stress responsive genes and signaling pathways, which open up new paradigms to augment rice productivity. Accordingly, transcription factors, protein kinases and enzymes for generating protective metabolites and proteins all contribute to an intricate network of events that guard and maintain cellular integrity. In addition, various quantitative trait loci associated with elevated stress tolerance have been cloned, resulting in the detection of novel genes for biotic and abiotic stress resistance. Mechanistic understanding of the genetic basis of traits, such as N and P use, is allowing rice researchers to engineer nutrient-efficient rice varieties, which would result in higher yields with lower inputs. Likewise, the research in micronutrients biosynthesis opens doors to genetic engineering of metabolic pathways to enhance micronutrients production. With third generation sequencing techniques on the horizon, exciting progress can be expected to vastly improve molecular markers for gene-trait associations forecast with increasing accuracy. This book emphasizes on the areas of rice science that attempt to overcome the foremost limitations in rice production. Our intention is to highlight research advances in the fields of physiology, molecular breeding and genetics, with a special focus on increasing productivity, improving biotic and abiotic stress tolerance and nutritional quality of rice. |
| bioaffinity technologies ipo date: The United Nations and Genocide Deborah Mayersen, 2018-05-15 The Convention on the Prevention and Punishment of the Crime of Genocide was the first human rights treaty adopted by the United Nations, reflecting the global commitment to 'never again' in the wake of the Holocaust. Seven decades on, The United Nations and Genocide examines how the UN has met, and failed to meet, the commitment to 'prevent and punish' the crime of genocide. It explores why the UN was unable to respond effectively to the genocides in Cambodia, Rwanda, the Balkans and Darfur, and considers new approaches recently adopted by the UN to address genocide. This volume asks the crucial question: can the UN protect peoples from genocide in the modern world? |
| bioaffinity technologies ipo date: Focus on Biotechnology Société de chimie industrielle (France). Branche belge, 2001 |
| bioaffinity technologies ipo date: Lucian's a true story Lucian (of Samosata.), Evan Hayes, Stephen A. Nimis, 2011 The aim of this book is to make Lucian's A True Story accessible to intermediate students of Ancient Greek. The running vocabulary and commentary are meant to provide everything necessary to read each page. Lucian's A True Story is a great text for intermediate readers. Its breathless narrative does not involve many complex sentences or constructions; there is some unusual vocabulary and a few departures from Attic Greek, but for the most part it is a straightforward narrative that is fun and interesting by one of antiquity's cleverest authors. In A True Story, Lucian parodies accounts of fanciful adventures and travel to incredible places by authors such as Ctesias and Iambulus. The story's combination of mockery and learning makes it an excellent example of the Greek literature of the imperial period. Revised August, 2014. |
| bioaffinity technologies ipo date: Advances in Polymer Science , 1985 |
| bioaffinity technologies ipo date: Encyclopedia of Metagenomics Sarah K. Highlander, Francisco Rodriguez-Valera, Bryan A White, 2015-01-03 Metagenomics has taken off as one of the major cutting-edge fields of research. The field has broad implications for human health and disease, animal production and environmental health. Metagenomics has opened up a wealth of data, tools, technologies and applications that allow us to access the majority of organisms that we still cannot access in pure culture (an estimated 99% of microbial life). Numerous research groups are developing tools, approaches and applications to deal with this new field, as larger data sets from environments including the human body, the oceans and soils are being generated. See for example the human microbiome initiative (HMP) which has become a world-wide effort and the Global Ocean Sampling (GOS) surveys. The number of publications as measured through PubMed that are focused on metagenomics continues to increase. The field of metagenomics continues to evolve with large common datasets available to the scientific community. A concerted effort is needed to collate all this information in a centralized place. By having all the information in an Encyclopedia form, we have an opportunity to receive seminal contributions from the leaders in the field and at the same time provide this information to a significant number of junior and senior scientists, via colleges, libraries, and just through online access. This format also allows scientists in the developing world to have continued access to this growing field. It is anticipated that the Encyclopedia will also be used by many other groups including, clinicians, undergraduate and graduate level students, as well as ethical and legal groups associated with or interested in the issues surrounding metagenome science. |
| bioaffinity technologies ipo date: Globalization and the Challenges of a New Century Patrick O'Meara, Howard D. Mehlinger, Matthew Krain, 2000-06-22 On world politics. |
| bioaffinity technologies ipo date: Containing Madness Jennifer M. Kilty, Erin Dej, 2018-07-28 This collection explores the discursive production and treatment of mental distress as it is mediated by gender and race in different institutional contexts. Featuring analyses of the prison, the psychiatric hospital, immigration detention, and other locales, this book explores the multiple interlocking oppressions that result in the diagnosis and medical, psychological, and psychiatric treatment of individuals constituted as ‘mentally ill’ at various historical moments and across institutional spaces. Contributors unpack how feminine, masculine, and transgender bodies are made up as mentally ill/sick/deviant by way of biomedical and institutional knowledges and discourses and are intervened upon by different institutional and expert authorities. |
| bioaffinity technologies ipo date: Myanmar in Transition Asian Development Bank, 2012-08-01 Myanmar, which is emerging from decades of isolation, is poised to accelerate its economic growth on the back of its abundant labor force, rich natural resources, and geographical location. But the country faces many development challenges to achieve strong and inclusive growth. To take advantage of its rich potential and endowments, Myanmar can also use its strategic location between the People's Republic of China and India, and act as a conduit between South and Southeast Asia. To sustain its growth momentum in the long run, Myanmar should aim for a growth trajectory that is inclusive, equitable, and environmentally sustainable. This special report assesses the country's strengths and weaknesses and highlights the challenges and risks. The key lies in prioritizing the actions to surmount the challenges and introducing the requisite reforms. |
| bioaffinity technologies ipo date: Computational Systems Biology Andres Kriete, Roland Eils, 2013-11-26 This comprehensively revised second edition of Computational Systems Biology discusses the experimental and theoretical foundations of the function of biological systems at the molecular, cellular or organismal level over temporal and spatial scales, as systems biology advances to provide clinical solutions to complex medical problems. In particular the work focuses on the engineering of biological systems and network modeling. - Logical information flow aids understanding of basic building blocks of life through disease phenotypes - Evolved principles gives insight into underlying organizational principles of biological organizations, and systems processes, governing functions such as adaptation or response patterns - Coverage of technical tools and systems helps researchers to understand and resolve specific systems biology problems using advanced computation - Multi-scale modeling on disparate scales aids researchers understanding of dependencies and constraints of spatio-temporal relationships fundamental to biological organization and function. |
| bioaffinity technologies ipo date: Agriculture, Rural Banking and Micro Finance in India Rais Ahmad, 2012 The agricultural sector occupies a key position in India's economy. It provides employment to about 65% of the working population of India. Being the backbone of India's economy, agriculture has been treated as a priority sector for the allocation of institutional credit. The low growth rate of agriculture in the past few years has further strengthened the channels of credit flow to this sector. Micro credit has emerged as a visible credit channel to the poor, as their access to conventional credit channels is constrained by the requirement of collateral and high transaction cost. Micro finance is routed through Self-Help Groups (SHGs). Over the years, the SHG-Bank Linkage Program - which includes commercial banks, regional rural banks, and co-operative banks - has emerged as the major micro finance program in the country. This book, authored by experts in the field of agricultural finance, provides an in-depth analysis of the current state of agricultural/rural finance in India, the emergence of micro finance, financial inclusion efforts, and related matters. |
| bioaffinity technologies ipo date: Co-operative Management and Development: Section IV: H.R.M. in co-operatives Rais Ahmad, 2009 In Indian context. |
| bioaffinity technologies ipo date: Banking and FDI in India Rais Ahmad, 2014 |
| bioaffinity technologies ipo date: Variation in Indigenous Minority Languages James N. Stanford, Dennis Richard Preston, 2009 Indigenous minority languages have played crucial roles in many areas of linguistics - phonetics, phonology, morphology, syntax, typology, and the ethnography of communication. Such languages have, however, received comparatively little attention from quantitative or variationist sociolinguistics. Without the diverse perspectives that underrepresented language communities can provide, our understanding of language variation and change will be incomplete. To help fill this gap and develop broader viewpoints, this anthology presents 21 original, fieldwork-based studies of a wide range of indigenous languages in the framework of quantitative sociolinguistics. The studies illustrate how such understudied communities can provide new insights into language variation and change with respect to socioeconomic status, gender, age, clan, lack of a standard, exogamy, contact with dominant majority languages, internal linguistic factors, and many other topics. |
| bioaffinity technologies ipo date: Agri-Business and Rural Management Rais Ahmad, 2013-01 India is the world's largest agrarian economy. However, now only 52 per cent of the workforce is engaged in the agriculture sector. This set of 9 books deals with various implications of agri-business and rural management. It incorporates 183 articles/research papers contributed by scholars. |
| bioaffinity technologies ipo date: Combating Fungal Infections Iqbal Ahmad, Mohammad Owais, Mohammed Shahid, Farrukh Aqil, 2010-08-03 Fungi are eukaryotic microorganisms that are closely related to humans at cellular level. Human fungal pathogens belong to various classes of fungi, mainly zygo- cetes, ascomycetes, basidiomycetes, and deuteromycetes. In recent years, fungal infections have dramatically increased as a result of improved diagnosis, high frequency of catheterization, instrumentation, etc. However, the main cause remains the increasing number of immunosuppressed patients, mostly because of HIV infection and indiscriminate usage of antineoplastic and immunosuppressive agents, broad-spectrum antibiotics and prosthetic devices, and grafts in clinical settings. Presently available means of combating fungal infections are still weak and clumsy compared to control of bacterial infection. The present scenario of antifungal therapy is still based on two classes of antifungal drugs (polyenes and azoles). These drugs are effective in many cases, but display toxicity and limited spectrum of ef?cacy. The recent trend towards emergence of drug-resistant isolates in the clinic is an additional problem. In recent years, a few new antifungal drugs have entered the clinics, but they are expected to undergo same fate as the older antifungal drugs. The application of fungal genomics offers an unparalleled opportunity to develop novel antifungal drugs. However, it is too early to expect any novel drugs, as the antifungal drug discovery program is in the stage of infancy. Interestingly, several novel antifungal drug targets have been identi?ed and validated. |
| bioaffinity technologies ipo date: Concrete Technology Practices Aminul Islam Laskar, 2015 Containing the fundamentals on the subject of concrete technology: hydration of cement, cement types, concrete making materials, workability, hardened properties of concrete, durability, mix design, chemical and mineral admixtures, and non-destructive testing, this book stands as a text book at undergraduate and postgraduate level in Civil Engineering in Universities, NITs and IITs. |
| bioaffinity technologies ipo date: Biomanagement of Metal-Contaminated Soils Mohammad Saghir Khan, Almas Zaidi, Reeta Goel, Javed Musarrat, 2011-08-30 Heavy-metal contamination is one of the world's major environmental problems, posing significant risks to agro-ecosystems. Conventional technologies employed for heavy-metal remediation have often been expensive and disruptive. This book provides comprehensive, state-of-the-art coverage of the natural, sustainable alternatives that use a wide range of biological materials in the removal/detoxification of heavy metals, consequently leading to the improvement of crops in these soils. Novel, environmentally friendly and inexpensive solutions are presented based on a sound understanding of metal contamination and the roles of plants and microbes in the management of these toxic soils. Written by worldwide experts, the book provides not only the necessary scientific background but also addresses the challenging questions that require special attention in order to better understand metal toxicity in soils and its management through bioremediation. |
| bioaffinity technologies ipo date: Environmental Protection Strategies for Sustainable Development Abdul Malik, Elisabeth Grohmann, 2011-09-18 The environment of our planet is degrading at an alarming rate because of non-sustainable urbanization, industrialization and agriculture. Unsustainable trends in relation to climate change and energy use, threats to public health, poverty and social exclusion, demographic pressure and ageing, management of natural resources, biodiversity loss, land use and transport still persist and new challenges are arising. Since these negative trends bring about a sense of urgency, short term action is required, whilst maintaining a longer term perspective. The main challenge is to gradually change our current unsustainable consumption and production patterns and the nonintegrated approach to policy-making. This book covers the broad area including potential of rhizospheric microorganisms in the sustainable plant development in anthropogenic polluted soils, bioremediation of pesticides from soil and waste water, toxic metals from soil, biological treatment of pulp and paper industry wastewater, sustainable solutions for agro processing waste management, solid waste management on climate change and human health, environmental impact of dyes and its remediation. Various methods for genotoxicity testing of environmental pollutants are also discussed and chapters on molecular detection of resistance and transfer genes in the environmental samples, biofilm formation by the environmental bacteria, biochemical attributes to assess soil ecosystem sustainability, application of rhizobacteria in biotechnology, role of peroxidases as a tool for the decolorization and removal of dyes and potential of biopesticides in sustainable agriculture. It offers a unique treatment of the subject, linking various protection strategies for sustainable development, describing the inter-relationships between the laboratory and field eco-toxicologist, the biotechnology consultant, environmental engineers and different international environmental regulatory and protection agencies. |
| bioaffinity technologies ipo date: Microbes and Microbial Technology Iqbal Ahmad, Farah Ahmad, John Pichtel, 2011-02-01 This book focuses on successful application of microbial biotechnology in areas such as medicine, agriculture, environment and human health. |
| bioaffinity technologies ipo date: Co-operatives and Rural Development in India Rais Ahmad, 2013 Ever since India's attainment of independence in 1947, alleviation of rural poverty has been one of the primary objectives of the country's planned economic development. The government of India has been striving to improve the economic and social conditions of rural populations through a host of measures, including the creation of productive employment opportunities based on optimal use of local raw materials and skills. It is undertaking interventions aimed at: (a) improving the supply chain, (b) enhancing skills, (c) upgrading technology, and (d) expanding markets and capacity building of the entrepreneurs/artisans and their groups/collectives. Having begun primarily in the field of credit as a defensive mechanism against the usurious money lenders, co-operatives have come to embrace a large gamut of activities to serve the interests of the producers and consumers. Credit, however, still continues to be the predominant activity. Co-operatives are expected to play a major role in the distribution of inputs and services to the farmers on the one hand and in assisting marketing and processing of agricultural produce on the other. This book contains research papers which provide deep insights into the complexities involved in rural development of India and the role which co-operatives can play in this stupendous task. |
| bioaffinity technologies ipo date: Microbial Strategies for Crop Improvement Mohammad Saghir Khan, Almas Zaidi, Javed Musarrat, 2009-08-25 With an ever-increasing human population, the demand placed upon the agriculture sector to supply more food is one of the greatest challenges for the agrarian community. In order to meet this challenge, environmentally unfriendly agroch- icals have played a key role in the green revolution and are even today commonly recommended to circumvent nutrient de?ciencies of the soils. The use of ag- chemicals is, though, a major factor for improvement of plant production; it causes a profound deteriorating effect on soil health (soil fertility) and in turn negatively affects the productivity and sustainability of crops. Concern over disturbance to the microbial diversity and consequently soil fertility (as these microbes are involved in biogeochemical processes), as well as economic constraints, have prompted fun- mental and applied research to look for new agro-biotechnologies that can ensure competitive yields by providing suf?ciently not only essential nutrients to the plants but also help to protect the health of soils by mitigating the toxic effects of certain pollutants. In this regard, the role of naturally abundant yet functionally fully unexplored microorganisms such as biofertilizers assume a special signi?cance in the context of supplementing plant nutrients, cost and environmental impact under both conventional practices and derelict environments. Therefore, current devel- ments in sustainability involve a rational exploitation of soil microbial communities and the use of inexpensive, though less bio-available, sources of plant nutrients, which may be made available to plants by microbially-mediated processes. |
| bioaffinity technologies ipo date: The Allure of Aligarh , 2021 |
| bioaffinity technologies ipo date: Computer-aided Process Plant Design Michael E. Leesley, 1982 |
8-K - 05/30/2025 - bioAffinity Technologies, Inc.
Pursuant to Nasdaq’s Listing Rules, the Company has 45 calendar days (until July 11, 2025), to submit a plan to regain compliance with the Rule (a “Compliance Plan”).
Filed April 11, 2025 - SEC.gov
bioAffinity Technologies, Inc. 3300 Nacogdoches Road San Antonio, TX 78217 Re: bioAffinity Technologies, Inc. Registration Statement on Form S-1 Filed April 11, 2025 File No. 333 …
8-K - 05/15/2025 - bioAffinity Technologies, Inc.
SAN ANTONIO, Texas (May 15, 2025) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for accurate, noninvasive tests for the detection …
BIOAFFINITY TECHNOLOGIES, INC. - RedChip
We believe that approval could occur by 2027. Over the longer term, we see the potential for bioAfinity to develop and market non-invasive tests for additional diseases, including chronic …
bioAffinity Technologies Reports First Quarter 2025 Results
May 15, 2025 · SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for accurate, noninvasive tests …
bioAffinity Technologies Inc. Warrant Annual Report 2025 …
reported by the Nasdaq Capital Market on such date was approximately $22.6 million. Shares of the registrant’s common stock held by each executive officer, director and holder of 5% or …
Bioaffinity Technologies, Inc. (Mon, Nov 04, 2024)
The Bioaffinity Technologies, Inc. stock price gained 0.234% on the last trading day (Monday, 4th Nov 2024), rising from $1.37 to $1.37. During the last trading day the stock fluctuated 2.13% …
8-K - 02/07/2025 - bioAffinity Technologies, Inc.
On February 7, 2025, bioAffinity Technologies, Inc. (the “Company”) received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying …
Bioaffinity Ipo (2024)
provides a unique perspective on the research and development of sensors microsystems and related technologies in Italy The scientific values of the papers also offers an invaluable source …
bioAffinity Technologies Reports First Quarter 2023 Financial …
the Company’s IPO in September 2022. Research and Development Highlights Received Notice of Allowance from the U.S. Patent and Trademark Office for a patent titled “Porphyrin …
bioAffinity Technologies Inc. Warrant Annual Report 2024 …
bioAffinity Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 46-5211056 (State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.) 22211 …
bioAffinity Technologies, Inc. DRS Letter.pdf - SEC.gov
bioAffinity Technologies' Diagnostic Product Pipeline, page 65 19. Please revise your pipeline chart to include a column for each phase of the FDA approval process.€ In addition, clarify …
FWP - 05/26/2022 - bioAffinity Technologies, Inc.
certain assumptions and analyses made by bioAffinity Technologies, Inc. in light of its experience and its assessment of historical trends, current conditions, and expected future developments …
Bioaffinity Technologies Ipo
Oct 18, 2023 · provides a unique perspective on the research and development of sensors, microsystems and related technologies in Italy. The scientific values of the papers also offers …
bioAffinity Technologies Reports Second Quarter 2023 …
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung …
Bioaffinity Ipo (2024)
provides a unique perspective on the research and development of sensors microsystems and related technologies in Italy The scientific values of the papers also offers an invaluable source …
Washington, D.C. 20549 SECURITIES AND EXCHANGE …
bioAffinity Technologies, Inc. (Exact name of registrant as specified in its charter) D e l aw are. 46-5211056 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer …
Bioaffinity Technologies Ipo Copy - archive.ncarb.org
Bioaffinity Technologies Ipo: Bestsellers in 2023 The year 2023 has witnessed a noteworthy surge in literary brilliance, with numerous captivating novels enthralling the hearts of readers …
424B4 - 09/02/2022 - bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc., a Delaware corporation headquartered in Texas (the “Company”), develops noninvasive, early-stage diagnostics to detect, and is researching targeted therapies …
Washington, D.C. 20549 SECURITIES AND EXCHANGE …
our anticipated uses of net proceeds from our initial public offering (“the IPO”) and subsequent direct offering (“the Direct Offering”);
8-K - 05/30/2025 - bioAffinity Technologies, Inc.
Pursuant to Nasdaq’s Listing Rules, the Company has 45 calendar days (until July 11, 2025), to submit a plan to regain compliance with the Rule (a “Compliance Plan”).
Filed April 11, 2025 - SEC.gov
bioAffinity Technologies, Inc. 3300 Nacogdoches Road San Antonio, TX 78217 Re: bioAffinity Technologies, Inc. Registration Statement on Form S-1 Filed April 11, 2025 File No. 333 …
8-K - 05/15/2025 - bioAffinity Technologies, Inc.
SAN ANTONIO, Texas (May 15, 2025) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for accurate, noninvasive tests for the detection …
BIOAFFINITY TECHNOLOGIES, INC. - RedChip
We believe that approval could occur by 2027. Over the longer term, we see the potential for bioAfinity to develop and market non-invasive tests for additional diseases, including chronic …
bioAffinity Technologies Reports First Quarter 2025 Results
May 15, 2025 · SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for accurate, noninvasive tests …
bioAffinity Technologies Inc. Warrant Annual Report 2025 …
reported by the Nasdaq Capital Market on such date was approximately $22.6 million. Shares of the registrant’s common stock held by each executive officer, director and holder of 5% or …
Bioaffinity Technologies, Inc. (Mon, Nov 04, 2024)
The Bioaffinity Technologies, Inc. stock price gained 0.234% on the last trading day (Monday, 4th Nov 2024), rising from $1.37 to $1.37. During the last trading day the stock fluctuated 2.13% …
8-K - 02/07/2025 - bioAffinity Technologies, Inc.
On February 7, 2025, bioAffinity Technologies, Inc. (the “Company”) received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying …
Bioaffinity Ipo (2024)
provides a unique perspective on the research and development of sensors microsystems and related technologies in Italy The scientific values of the papers also offers an invaluable source …
bioAffinity Technologies Reports First Quarter 2023 …
the Company’s IPO in September 2022. Research and Development Highlights Received Notice of Allowance from the U.S. Patent and Trademark Office for a patent titled “Porphyrin …
bioAffinity Technologies Inc. Warrant Annual Report 2024 …
bioAffinity Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 46-5211056 (State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.) 22211 …
bioAffinity Technologies, Inc. DRS Letter.pdf - SEC.gov
bioAffinity Technologies' Diagnostic Product Pipeline, page 65 19. Please revise your pipeline chart to include a column for each phase of the FDA approval process.€ In addition, clarify …
FWP - 05/26/2022 - bioAffinity Technologies, Inc.
certain assumptions and analyses made by bioAffinity Technologies, Inc. in light of its experience and its assessment of historical trends, current conditions, and expected future developments …
Bioaffinity Technologies Ipo
Oct 18, 2023 · provides a unique perspective on the research and development of sensors, microsystems and related technologies in Italy. The scientific values of the papers also offers …
bioAffinity Technologies Reports Second Quarter 2023 …
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung …
Bioaffinity Ipo (2024)
provides a unique perspective on the research and development of sensors microsystems and related technologies in Italy The scientific values of the papers also offers an invaluable source …
Washington, D.C. 20549 SECURITIES AND EXCHANGE …
bioAffinity Technologies, Inc. (Exact name of registrant as specified in its charter) D e l aw are. 46-5211056 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer …
Bioaffinity Technologies Ipo Copy - archive.ncarb.org
Bioaffinity Technologies Ipo: Bestsellers in 2023 The year 2023 has witnessed a noteworthy surge in literary brilliance, with numerous captivating novels enthralling the hearts of readers …
424B4 - 09/02/2022 - bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc., a Delaware corporation headquartered in Texas (the “Company”), develops noninvasive, early-stage diagnostics to detect, and is researching targeted therapies …
Washington, D.C. 20549 SECURITIES AND EXCHANGE …
our anticipated uses of net proceeds from our initial public offering (“the IPO”) and subsequent direct offering (“the Direct Offering”);
